Impact of prior vaccination with Covishield(TM) and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study

BACKGROUND: COVID-19 vaccines were authorised for emergency use to mitigate the impact of the pandemic. This study evaluated the effect of prior vaccination with either Oxford Astra Zeneca’s Covishield™ or Bharath Biotech’s Covaxin® on mortality among symptomatic COVID-19 patients during the second...

Descripción completa

Detalles Bibliográficos
Autores principales: Abhilash, Kundavaram Paul Prabhakar, Mathiyalagan, Ponnivalavan, Krishnaraj, Vivek Raja K., Selvan, Saravanan, Kanagarajan, Rohini, Reddy, Narmadha P., Rajendiran, Natarajan, Hazra, Darpanarayan, Gunasekaran, Karthik, Moorthy, Mahesh, Jasmine, Sudha, Davis, John Prasad, George, Tina, George, Krupa, Varghese, George M., Rupali, Priscilla, Barney Isaac, T.J., Gupta, Richa, Pichamuthu, Kishore, Joy, Melvin, Jayaseelan, Lakshmanan, Mathews, Prasad, Peter, John Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828422/
https://www.ncbi.nlm.nih.gov/pubmed/35168837
http://dx.doi.org/10.1016/j.vaccine.2022.02.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828422/
https://www.ncbi.nlm.nih.gov/pubmed/35168837
http://dx.doi.org/10.1016/j.vaccine.2022.02.023

Ejemplares similares